MedTrace Logo

Fibromyalgia Syndrome in France: The Role of Assessment and Management of Sleep Disorders

NCT04775368 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 601

Last updated 2023-05-01

No results posted yet for this study

Summary

The FIBOBS study is a multi-centered, observational, prospective study carried out within specialized chronic pain structures (CPS) in France. It will estimate the prevalence of sleep disorders, divided into three categories (poor quality of sleep in general, sleep apnea syndrome, restless legs syndrome), using self-questionnaires in patients with Fibromyalgia Syndrome (FMS) consulting within a CPS. The interaction between these sleep disorders and other symptoms of FMS will also be analyzed using self-administered questionnaires. Based on the hypothesis that sleep disorders associated with FMS are only imperfectly assessed and/or treated in CPS, the FIBOBS study will also interview pain physician in order to know both the diagnostic tools used and the recommended management when sleep disorders are suspected in the context of FMS. In addition, this study will provide a better understanding of the symptoms of FMS, their impact and how patients feel.

Conditions

  • Fibromyalgia

Interventions

OTHER

Administering diagnosis orientation questionnaires for the screening of possible sleep disorders

Several diagnosis orientation self-questionnaires will be conducted by the patient following his or her inclusion in order to detect, among other things, possible sleep disorders.

Sponsors & Collaborators

  • Walisco

    collaborator UNKNOWN

  • University Hospital, Clermont-Ferrand

    collaborator OTHER

  • Centre Hospitalier Emile Roux

    lead OTHER

Principal Investigators

  • Gilbert ANDRE, MD · CH Emile Roux - Le Puy-en-Velay

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2023-03-07
Completion
2023-03-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04775368 on ClinicalTrials.gov